Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 479061 - 479080 out of 485260 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (R03DX07) roflumilast (adm: O) | DALIRESP 500MCG TAB | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (R03DX07) roflumilast (adm: O) | DALIRESP 500MCG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (R03DX07) roflumilast (adm: O) | DALIRESP 500MCG TAB | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (R03DX07) roflumilast (adm: O) | ZORYVE 0.3% CREAM,TOP | 60GM | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | ArcutisBiotherapeutics,Inc. |
| USA | (R03DX08) reslizumab (adm: P) | CINQAIR(RESLIZUMAB 10MG/ML INJ,SOLN 10ML SDV | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsUSA,Inc. |
| USA | (R03DX08) reslizumab (adm: P) | CINQAIR(RESLIZUMAB 10MG/ML INJ,SOLN 10ML SDV | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsUSA,Inc. |
| USA | (R03DX09) mepolizumab (adm: P) | NUCALA 100MG/ML,AUTO INJCT | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma | GlaxoSmithKline |
| USA | (R03DX09) mepolizumab (adm: P) | NUCALA 100MG/ML,SYRINGE | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma | GlaxoSmithKline |
| USA | (R03DX09) mepolizumab (adm: P) | NUCALA 40MG/0.4ML INJ,SYR | 0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma | GlaxoSmithKline |
| USA | (R03DX09) mepolizumab (adm: P) | NUCALA 100MG INJ | 100MG | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma | GlaxoSmithKline |
| USA | (R03DX09) mepolizumab (adm: P) | NUCALA 100MG INJ | 100MG | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma | GlaxoSmithKline |
| USA | (R03DX10) benralizumab (adm: P) | FASENRA 30MG/ML INJ,PEN,1ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (R03DX10) benralizumab (adm: P) | FASENRA 30MG/ML INJ,PEN,1ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (R03DX10) benralizumab (adm: P) | FASENRA 30MG/ML INJ,SYR,1ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (R03DX10) benralizumab (adm: P) | FASENRA 30MG/ML INJ,SYR,1ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (R03DX11) tezepelumab (adm: P) | TEZSPIRE 210MG | 1.91ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma | AmgenUSA,Inc. |
| USA | (R03DX11) tezepelumab (adm: P) | TEZSPIRE 210MG | 1.91ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma | AmgenUSA,Inc. |
| USA | (R03DX11) tezepelumab (adm: P) | TEZSPIRE 210MG/1.91ML INJ,SYRINGE,1.9 | 1.91ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma | AmgenUSA,Inc. |
| USA | (R03DX11) tezepelumab (adm: P) | TEZSPIRE 210MG/1.91ML INJ,SYRINGE,1.9 | 1.91ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma | AmgenUSA,Inc. |
| USA | (R05CB13) dornase alfa (desoxyribonuclease) (adm: Inhal.solution) | PULMOZYME 2.5ML AMP (6/PACK) | 5X6 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenentechUSA,Inc. |
Pages
